Language
English
Publication Date
5-1-2021
Journal
Reviews in Medical Virology
DOI
10.1002/rmv.2172
PMID
32959951
PMCID
PMC7536956
PubMedCentral® Posted Date
9-22-2020
PubMedCentral® Full Text Version
Post-print
Abstract
Severe acute respiratory syndrome coronavirus-2 causes the clinical syndrome of coronavirus disease of 2019 (COVID-19) which has become a global pandemic resulting in significant morbidity and mortality. While the virus primarily affects the respiratory system, it also causes a wide variety of complex cardiac manifestations such as acute myopericarditis, acute coronary syndrome, congested heart failure, cardiogenic shock and cardiac arrhythmias. There are numerous proposed mechanisms of cardiac injury, including direct cellular injury, pro-inflammatory cytokine storm, myocardial oxygen-demand mismatch, and systemic inflammation causing multi-organ failure. Additionally, medications commonly used to treat COVID-19 patients have various cardiovascular side effects. We aim to provide a succinct review about the pathophysiology and cardiac manifestations of COVID-19, as well as treatment considerations and the various adaptations made to the current healthcare structure as a result of the pandemic.
Keywords
Acute Coronary Syndrome, Antiviral Agents, Arrhythmias, Cardiac, Biomarkers, COVID-19, Cardiac Catheterization, Comorbidity, Disease Management, Glucocorticoids, Heart Failure, Hospitalization, Humans, Immunologic Factors, Pandemics, Pericarditis, Risk Factors, SARS-CoV-2, Severity of Illness Index, Shock, Cardiogenic, Texas
Published Open-Access
yes
Recommended Citation
Liu, Jing; Virani, Salim S; Alam, Mahboob; et al., "Coronavirus Disease-19 and Cardiovascular Disease: A Risk Factor or a Risk Marker?" (2021). Faculty and Staff Publications. 966.
https://digitalcommons.library.tmc.edu/baylor_docs/966
Included in
Cardiology Commons, Cardiovascular Diseases Commons, COVID-19 Commons, Epidemiology Commons, Medical Sciences Commons, Pulmonology Commons, Respiratory Tract Diseases Commons